Literature DB >> 16344560

Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.

Kouichi Kimura1, Ai Wakamatsu, Yutaka Suzuki, Toshio Ota, Tetsuo Nishikawa, Riu Yamashita, Jun-ichi Yamamoto, Mitsuo Sekine, Katsuki Tsuritani, Hiroyuki Wakaguri, Shizuko Ishii, Tomoyasu Sugiyama, Kaoru Saito, Yuko Isono, Ryotaro Irie, Norihiro Kushida, Takahiro Yoneyama, Rie Otsuka, Katsuhiro Kanda, Takahide Yokoi, Hiroshi Kondo, Masako Wagatsuma, Katsuji Murakawa, Shinichi Ishida, Tadashi Ishibashi, Asako Takahashi-Fujii, Tomoo Tanase, Keiichi Nagai, Hisashi Kikuchi, Kenta Nakai, Takao Isogai, Sumio Sugano.   

Abstract

By analyzing 1,780,295 5'-end sequences of human full-length cDNAs derived from 164 kinds of oligo-cap cDNA libraries, we identified 269,774 independent positions of transcriptional start sites (TSSs) for 14,628 human RefSeq genes. These TSSs were clustered into 30,964 clusters that were separated from each other by more than 500 bp and thus are very likely to constitute mutually distinct alternative promoters. To our surprise, at least 7674 (52%) human RefSeq genes were subject to regulation by putative alternative promoters (PAPs). On average, there were 3.1 PAPs per gene, with the composition of one CpG-island-containing promoter per 2.6 CpG-less promoters. In 17% of the PAP-containing loci, tissue-specific use of the PAPs was observed. The richest tissue sources of the tissue-specific PAPs were testis and brain. It was also intriguing that the PAP-containing promoters were enriched in the genes encoding signal transduction-related proteins and were rarer in the genes encoding extracellular proteins, possibly reflecting the varied functional requirement for and the restricted expression of those categories of genes, respectively. The patterns of the first exons were highly diverse as well. On average, there were 7.7 different splicing types of first exons per locus partly produced by the PAPs, suggesting that a wide variety of transcripts can be achieved by this mechanism. Our findings suggest that use of alternate promoters and consequent alternative use of first exons should play a pivotal role in generating the complexity required for the highly elaborated molecular systems in humans.

Entities:  

Mesh:

Year:  2005        PMID: 16344560      PMCID: PMC1356129          DOI: 10.1101/gr.4039406

Source DB:  PubMed          Journal:  Genome Res        ISSN: 1088-9051            Impact factor:   9.043


  45 in total

1.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

2.  The Eukaryotic Promoter Database EPD: the impact of in silico primer extension.

Authors:  Christoph D Schmid; Viviane Praz; Mauro Delorenzi; Rouaïda Périer; Philipp Bucher
Journal:  Nucleic Acids Res       Date:  2004-01-01       Impact factor: 16.971

3.  Antisense transcripts with FANTOM2 clone set and their implications for gene regulation.

Authors:  Hidenori Kiyosawa; Itaru Yamanaka; Naoki Osato; Shinji Kondo; Yoshihide Hayashizaki
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

4.  Impact of alternative initiation, splicing, and termination on the diversity of the mRNA transcripts encoded by the mouse transcriptome.

Authors:  Mihaela Zavolan; Shinji Kondo; Christian Schonbach; Jun Adachi; David A Hume; Yoshihide Hayashizaki; Terry Gaasterland
Journal:  Genome Res       Date:  2003-06       Impact factor: 9.043

Review 5.  Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation.

Authors:  A J Lopez
Journal:  Annu Rev Genet       Date:  1998       Impact factor: 16.830

6.  Systematic discovery of regulatory motifs in human promoters and 3' UTRs by comparison of several mammals.

Authors:  Xiaohui Xie; Jun Lu; E J Kulbokas; Todd R Golub; Vamsi Mootha; Kerstin Lindblad-Toh; Eric S Lander; Manolis Kellis
Journal:  Nature       Date:  2005-02-27       Impact factor: 49.962

7.  The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter.

Authors:  Andrea Ventura; Lucilla Luzi; Sonia Pacini; Cosima T Baldari; Pier Giuseppe Pelicci
Journal:  J Biol Chem       Date:  2002-04-10       Impact factor: 5.157

Review 8.  Life with 6000 genes.

Authors:  A Goffeau; B G Barrell; H Bussey; R W Davis; B Dujon; H Feldmann; F Galibert; J D Hoheisel; C Jacq; M Johnston; E J Louis; H W Mewes; Y Murakami; P Philippsen; H Tettelin; S G Oliver
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

9.  The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints.

Authors:  Robert Fredriksson; Malin C Lagerström; Lars-Gustav Lundin; Helgi B Schiöth
Journal:  Mol Pharmacol       Date:  2003-06       Impact factor: 4.436

10.  Entrez Gene: gene-centered information at NCBI.

Authors:  Donna Maglott; Jim Ostell; Kim D Pruitt; Tatiana Tatusova
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

View more
  231 in total

1.  What is a functional locus? Understanding the genetic basis of complex phenotypic traits.

Authors:  Edward A Ruiz-Narváez
Journal:  Med Hypotheses       Date:  2011-02-01       Impact factor: 1.538

Review 2.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

3.  In silico analysis of regulatory and structural motifs of the ovine HSP90AA1 gene.

Authors:  Carmen González; Judit Salces-Ortiz; Jorge H Calvo; M Magdalena Serrano
Journal:  Cell Stress Chaperones       Date:  2016-01-26       Impact factor: 3.667

4.  SPOCD1 promotes the proliferation and metastasis of glioma cells by up-regulating PTX3.

Authors:  Quan Liu; Xiao-Yu Wang; Yuan-Yuan Qin; Xian-Lei Yan; Hong-Mou Chen; Qi-Dan Huang; Jia-Kang Chen; Jie-Min Zheng
Journal:  Am J Cancer Res       Date:  2018-04-01       Impact factor: 6.166

5.  Several cis-regulatory elements control mRNA stability, translation efficiency, and expression pattern of Prrxl1 (paired related homeobox protein-like 1).

Authors:  Isabel Regadas; Mariana Raimundo Matos; Filipe Almeida Monteiro; José Luis Gómez-Skarmeta; Deolinda Lima; José Bessa; Fernando Casares; Carlos Reguenga
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

6.  An alternative transcript of the Alzheimer's disease risk gene SORL1 encodes a truncated receptor.

Authors:  Jenny Blechingberg; Annemarie Svane Aavild Poulsen; Mads Kjølby; Giulia Monti; Mariet Allen; Anne Kathrine Ivarsen; Sarah J Lincoln; Gangadaar Thotakura; Christian B Vægter; Nilüfer Ertekin-Taner; Anders Nykjær; Olav M Andersen
Journal:  Neurobiol Aging       Date:  2018-06-28       Impact factor: 4.673

7.  Genome-wide analysis of alternative transcripts in human breast cancer.

Authors:  Ji Wen; Kevin H Toomer; Zhibin Chen; Xiaodong Cai
Journal:  Breast Cancer Res Treat       Date:  2015-04-26       Impact factor: 4.872

8.  Targeted discovery of novel human exons by comparative genomics.

Authors:  Adam Siepel; Mark Diekhans; Brona Brejová; Laura Langton; Michael Stevens; Charles L G Comstock; Colleen Davis; Brent Ewing; Shelly Oommen; Christopher Lau; Hung-Chun Yu; Jianfeng Li; Bruce A Roe; Phil Green; Daniela S Gerhard; Gary Temple; David Haussler; Michael R Brent
Journal:  Genome Res       Date:  2007-11-07       Impact factor: 9.043

9.  The Human Pseudoautosomal Region (PAR): Origin, Function and Future.

Authors:  A Helena Mangs; Brian J Morris
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

10.  Analysis and synthesis of high-amplitude Cis-elements in the mammalian circadian clock.

Authors:  Yuichi Kumaki; Maki Ukai-Tadenuma; Ken-ichiro D Uno; Junko Nishio; Koh-hei Masumoto; Mamoru Nagano; Takashi Komori; Yasufumi Shigeyoshi; John B Hogenesch; Hiroki R Ueda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.